Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities
Net income	$ 26,451	$ 29,096
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes	857	(1,215)
Provision for credit losses	550
Depreciation and amortization	6,378	6,116
Amortization and accretion of premiums/discounts on investment securities	1,652	2,778
Amortization of operating lease right-of-use assets	1,756	(65)
Share-based compensation expense	1,192	1,392
Originations on loans held for sale	(239,004)	(353,547)
Proceeds on loans held for sale	238,028	383,740
(Increase) in value of bank-owned life insurance	(653)	(621)
Realized loss (gain) on sale of fixed assets	(71)	(33)
Realized loss (gain) on derivative instruments	531	1,031
Realized loss (gain) on loans sold	(5,922)	(10,062)
Realized loss (gain) on sale of foreclosed assets	(27)	(9)
Realized loss (gain) on BOLI mortality	(1,196)
Realized loss (gain) on servicing rights	(28)	(683)
Net change in:
Accrued interest receivable	(2,692)	(1,628)
Other assets	4,784	(13,903)
Accrued expenses and other liabilities	(1,986)	12,348
Net cash provided (used) by operating activities	30,600	54,735
Investing Activities
Proceeds from maturities of investment securities available-for-sale	46,655	88,417
Purchases of investment securities available-for-sale		(96,968)
Proceeds from calls of investment securities held-to-maturity	242	827
Proceeds from maturities and paydowns of investment securities held-to-maturity	17,125	23,422
Net (increase) decrease in loans	(161,606)	(290,565)
Net (increase) decrease in FHLB stock	(5,953)
Net cash received (paid) for business combinations		101,585
Proceeds from BOLI mortality claim	2,828
Purchases of premises and equipment	(1,731)	(1,081)
Proceeds from sales of foreclosed assets	51	143
Net cash provided (used) by investing activities	(102,389)	(174,220)
Financing Activities
Net increase (decrease) in deposits	(43,300)	(312,425)
Net increase (decrease) in short-term borrowings	137,390	253,830
Repayments of long-term debt		(182)
Cash dividends paid on common stock	(11,263)	(9,185)
Repurchase of common stock	(4,556)	(697)
Net cash provided (used) by financing activities	78,271	(68,659)
Net change in cash and cash equivalents	6,482	(188,144)
Cash and cash equivalents at beginning of period	58,242	242,311
Cash and cash equivalents at end of period	64,724	54,167
Supplemental Cash Flow Disclosures
Interest paid	50,969	7,269
Income taxes paid	6,637	8,713
Cash dividends declared, not paid	3,838	3,615
Supplemental Disclosures of Noncash Investing and Financing Activities
Loan collateral transferred to foreclosed assets	3	153
Right-of-use assets obtained in exchange for new operating lease liabilities, net	1,938	$ 1,452
Change in fair value hedges presented within residential real estate loans and other assets	$ 3,206